Modeling the Time Evolution of the Nanoparticle-Protein Corona in a Body Fluid

Background Nanoparticles in contact with biological fluids interact with proteins and other biomolecules, thus forming a dynamic corona whose composition varies over time due to continuous protein association and dissociation events. Eventually equilibrium is reached, at which point the continued exchange will not affect the composition of the corona. Results We developed a simple and effective dynamic model of the nanoparticle protein corona in a body fluid, namely human plasma. The model predicts the time evolution and equilibrium composition of the corona based on affinities, stoichiometries and rate constants. An application to the interaction of human serum albumin, high density lipoprotein (HDL) and fibrinogen with 70 nm N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles is presented, including novel experimental data for HDL. Conclusions The simple model presented here can easily be modified to mimic the interaction of the nanoparticle protein corona with a novel biological fluid or compartment once new data will be available, thus opening novel applications in nanotoxicity and nanomedicine.

[1]  E. Magid,et al.  International federation of clinical chemistry , 1996 .

[2]  David Farrar,et al.  Surface tailoring for controlled protein adsorption: effect of topography at the nanometer scale and chemistry. , 2006, Journal of the American Chemical Society.

[3]  H. Argani,et al.  Effect of L-Carnitine on the Serum Lipoproteins and HDL-C Subclasses in Hemodialysis Patients , 2005, Nephron Clinical Practice.

[4]  C. Kalofoutis,et al.  Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease. , 2001, Journal of diabetes and its complications.

[5]  C. Kalofoutis,et al.  Evidence of reduced plasma HDL subfractions in patients with cutaneous discoid lupus erythematosus. , 2005, Clinical biochemistry.

[6]  Sara Linse,et al.  Complete high‐density lipoproteins in nanoparticle corona , 2009, The FEBS journal.

[7]  David Farrar,et al.  Interpretation of protein adsorption: surface-induced conformational changes. , 2005, Journal of the American Chemical Society.

[8]  N. Anderson,et al.  The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.

[9]  R J Havel,et al.  Introduction to the plasma lipoproteins. , 1986, Methods in enzymology.

[10]  G. Hortin.  The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome. , 2006, Clinical chemistry.

[11]  D. Dell’Orco,et al.  Network-level analysis of light adaptation in rod cells under normal and altered conditions. , 2009, Molecular bioSystems.

[12]  Sara Linse,et al.  Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. , 2007, Angewandte Chemie.

[13]  B. Dahlbäck,et al.  Anionic Phospholipids Lose Their Procoagulant Properties When Incorporated into High Density Lipoproteins* , 2009, Journal of Biological Chemistry.

[14]  Mats Jirstrand,et al.  Systems biology Systems Biology Toolbox for MATLAB : a computational platform for research in systems biology , 2006 .

[15]  K. Dawson,et al.  Systematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles. Effects of particle size and hydrophobicity. , 2007, Nano letters.

[16]  T. Creighton.  Methods in Enzymology , 1968, The Yale Journal of Biology and Medicine.

[17]  Sara Linse,et al.  Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[18]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.